James P. Tursi

1.8k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

James P. Tursi is a scholar working on Surgery, Psychiatry and Mental health and Rheumatology. According to data from OpenAlex, James P. Tursi has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 20 papers in Psychiatry and Mental health and 15 papers in Rheumatology. Recurrent topics in James P. Tursi's work include Genital Health and Disease (20 papers), Sexual function and dysfunction studies (20 papers) and Dupuytren's Contracture and Treatments (15 papers). James P. Tursi is often cited by papers focused on Genital Health and Disease (20 papers), Sexual function and dysfunction studies (20 papers) and Dupuytren's Contracture and Treatments (15 papers). James P. Tursi collaborates with scholars based in United States, Australia and United Kingdom. James P. Tursi's co-authors include Gregory J. Kaufman, Ted Smith, Martin K. Gelbard, Wayne J.G. Hellstrom, Nigel Jones, Irwin Goldstein, Culley C. Carson, Chris G. McMahon, Laurence A. Levine and Stephen Coleman and has published in prestigious journals such as The Journal of Urology, Obstetrics and Gynecology and Urology.

In The Last Decade

James P. Tursi

36 papers receiving 1.2k citations

Hit Papers

Clinical Efficacy, Safety and Tolerability of Collagenase... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
    2013 316 citations Martin K. Gelbard, Irwin Goldstein et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James P. Tursi United States 16 809 799 545 282 186 37 1.3k
Martin K. Gelbard United States 19 969 1.2× 1.5k 1.9× 407 0.7× 707 2.5× 458 2.5× 41 1.8k
Stanton Honig United States 18 420 0.5× 387 0.5× 130 0.2× 187 0.7× 169 0.9× 62 1.1k
Kostis Gyftopoulos Greece 18 208 0.3× 187 0.2× 349 0.6× 505 1.8× 178 1.0× 48 985
Emre Akkuş Türkiye 10 296 0.4× 620 0.8× 146 0.3× 307 1.1× 357 1.9× 26 822
Javaad Zargooshi Iran 17 583 0.7× 203 0.3× 309 0.6× 513 1.8× 68 0.4× 34 1.1k
Richard F. Labasky United States 9 374 0.5× 399 0.5× 107 0.2× 463 1.6× 341 1.8× 11 949
Carlo Pavone Italy 15 283 0.3× 228 0.3× 143 0.3× 342 1.2× 136 0.7× 78 787
David Nunns United Kingdom 13 172 0.2× 294 0.4× 153 0.3× 70 0.2× 63 0.3× 55 784
Wayland Hsiao United States 20 293 0.4× 155 0.2× 118 0.2× 111 0.4× 142 0.8× 41 1.0k
Ercüment Ulusoy Türkiye 14 106 0.1× 243 0.3× 287 0.5× 272 1.0× 99 0.5× 25 695

Countries citing papers authored by James P. Tursi

Since Specialization
Citations

This map shows the geographic impact of James P. Tursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Tursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Tursi more than expected).

Fields of papers citing papers by James P. Tursi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Tursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Tursi. The network helps show where James P. Tursi may publish in the future.

Co-authorship network of co-authors of James P. Tursi

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Tursi. A scholar is included among the top collaborators of James P. Tursi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Tursi. James P. Tursi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogiatzi, Maria G., et al.. (2020). Testosterone Use in Adolescent Males: Current Practice and Unmet Needs. Journal of the Endocrine Society. 5(1). bvaa161–bvaa161. 12 indexed citations
2.
Peimer, Clayton A., et al.. (2017). Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum. The Journal Of Hand Surgery. 42(5). 391.e1–391.e8. 22 indexed citations
3.
Zhang, Wenjie, Yi Han, John G. Fort, David Schofield, & James P. Tursi. (2017). The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events. Journal of Medical Economics. 20(6). 592–598. 2 indexed citations
4.
Goldstein, Irwin, D. Knoll, Larry I. Lipshultz, et al.. (2016). PS-06-007 Changes in the Effects of Peyronie's Disease After Treatment with Collagenase Clostridium Histolyticum According to Men with Peyronie's Disease and Their Female Sexual Partners. The Journal of Sexual Medicine. 13(Supplement_2). S103–S104. 1 indexed citations
5.
Gelbard, Martin K., et al.. (2015). Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach. The Journal of Sexual Medicine. 12(6). 1481–1489. 14 indexed citations
6.
Gaston, R. Glenn, Søren Erik Larsen, Gary M. Pess, et al.. (2015). The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study. The Journal Of Hand Surgery. 40(10). 1963–1971. 48 indexed citations
7.
Hellstrom, Wayne J.G., Robert Feldman, Karin S. Coyne, et al.. (2015). Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies. Urology. 86(2). 291–299. 18 indexed citations
8.
Levine, Laurence A., Martin K. Gelbard, James P. Tursi, et al.. (2015). PD48-06 OUTCOMES ASSOCIATED WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE'S DISEASE BY DURATION OF DISEASE. The Journal of Urology. 193(4S). 1 indexed citations
9.
Wang, Edward D., et al.. (2015). Phase 2a Study of Safety/Efficacy of Collagenase (CCH) in Patients with Adhesive Capsulitis. The Journal Of Hand Surgery. 40(9). e50–e50. 2 indexed citations
10.
Goldstein, Irwin, Larry I. Lipshultz, James P. Tursi, et al.. (2015). PD48-07 CHANGES IN THE EFFECTS OF PEYRONIE'S DISEASE AFTER TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ACCORDING TO MEN WITH PEYRONIE'S DISEASE AND THEIR FEMALE SEXUAL PARTNERS. The Journal of Urology. 193(4S). 2 indexed citations
11.
Hellstrom, Wayne J.G., Jed Kaminetsky, Laurence Belkoff, et al.. (2015). Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study. The Journal of Urology. 194(2). 485–492. 24 indexed citations
12.
Hurst, Lawrence C., R. Glenn Gaston, Richard A. Brown, et al.. (2014). Prospective Multicenter, Multinational Study to Evaluate the Safety and Efficacy of Concurrent Collagenase Clostridium Histolyticum Injections to Concurrently Treat 2 Dupuytren Contractures in the Same Hand. The Journal Of Hand Surgery. 39(9). e32–e33. 1 indexed citations
13.
Hotchkiss, Robert N., et al.. (2013). Recurrence of Dupuytren Contracture After Nonsurgical Treatment With Collagenase Clostridium Histolyticum: Summary of 4-Year CORDLESS Data. The Journal Of Hand Surgery. 38(10). e53–e54. 2 indexed citations
14.
Coleman, Stephen, David Gilpin, F. Thomas D. Kaplan, et al.. (2013). Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for Multiple Dupuytren Contractures. The Journal Of Hand Surgery. 39(1). 57–64. 57 indexed citations
15.
Gelbard, Martin K., Irwin Goldstein, Wayne J.G. Hellstrom, et al.. (2013). Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies. The Journal of Urology. 190(1). 199–207. 316 indexed citations breakdown →
16.
Gelbard, Martin K., Wayne J.G. Hellstrom, Chris G. McMahon, et al.. (2013). Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease. The Journal of Sexual Medicine. 10(11). 2822–2831. 39 indexed citations
17.
Peimer, Clayton A., Philip Blazar, Stephen Coleman, et al.. (2012). Dupuytren Contracture Recurrence Following Treatment with Collagenase Clostridium Histolyticum (CORDLESS Study): 3-Year Data. The Journal Of Hand Surgery. 38(1). 12–22. 112 indexed citations
18.
Coleman, Stephen, et al.. (2012). Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study. BMC Musculoskeletal Disorders. 13(1). 61–61. 32 indexed citations
19.
Kaplan, F. Thomas D., et al.. (2012). Patterns of Recurrent Contracture in Patients with Dupuytren's Disease 3 Years Following Successful Treatment with Collagenase Clostridium Histolyticum. The Journal Of Hand Surgery. 37(8). 14–14. 3 indexed citations
20.
Tursi, James P., Uma M. Reddy, & George R. Huggins. (1993). Cholelithiasis of the ovary. Obstetrics and Gynecology. 82(4). 653–654. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin K. Gelbard Breakdown of academic impact, for papers by Stanton Honig Breakdown of academic impact, for papers by Kostis Gyftopoulos Breakdown of academic impact, for papers by Emre Akkuş Breakdown of academic impact, for papers by Javaad Zargooshi Breakdown of academic impact, for papers by Richard F. Labasky Breakdown of academic impact, for papers by Carlo Pavone Breakdown of academic impact, for papers by David Nunns Breakdown of academic impact, for papers by Wayland Hsiao Breakdown of academic impact, for papers by Ercüment Ulusoy
Rankless by CCL
2026